Glyphosate Facts

Transparency on safety aspects and use of glyphosate-containing herbicides in Europe


Webinar: Specific target organ toxicity after repeated exposure (STOT-RE) – Does a classification for glyphosate need to be considered?

November 28, 4:00 PM – 6:30 PM CET

If you have any questions or comments on the webinar, please do not hesitate to contact us.

During this webinar Dr. Martens will examine the need to classify glyphosate for STOT-RE. Dr. Martens will focus on all the evidence available from different animal models (rat -mouse-dog and rabbit) and assess whether the classification criteria have been met. In this assessment the endpoints, the mechanism of toxicity (it is relevance to humans) and the overall weight of evidence will be considered.

Dr. Mark Martens is a Consultant in preclinical development and toxicology (MMTA bvba). Admitted to the European Register of Toxicology (ERT), Dr. Martens was previously Vice President for pre-clinical development of the virology franchise of Johnson & Johnson. Prior to his time at J&J, Dr. Martens was in charge of both toxicology agriculture R&D at Monsanto Europe and also acted as Head of Department of toxicology of the Scientific Institute of Public Health in Brussels where he was involved with bodies such as the European Commission, the OECD, IPCS, IARC and ECETOC programmes on chemical risk assessment and toxicology testing. Dr. Martens holds both a Master and PhD in pharmaceutical sciences from the University of Ghent, Belgium where he specialised in toxicology, phytopharmacy, hematology, industrial pharmacy and clinical biochemistry. Dr. Martens has produced numerous publications, presentations and posters in the fields of clinical, forensic, experimental and regulatory toxicology, and drug metabolism and pharmacokinetics. He is also the Co-author of a book on global new drug development (ULLA postgraduate pharmacy series, Wiley-Blackwell, 2014).

Last update: 16 December 2016